See what 20 biotech hedge funds are buying, before the headlines.
Every position change, insider trade, and clinical catalyst, explained in plain English.
$44.2B+
Smart Money Tracked
across 20 specialist funds
1570+
Biotech Companies
cross-referenced
2793+
Upcoming Catalysts
PDUFAs, Phase 2/3, AdComs
May 13
Latest Filing Parsed
from SEC EDGAR, daily
Funds we track
Driehaus Capital
208 holdings
Eventide Asset Management
153 holdings
Rock Springs Capital
73 holdings
OrbiMed Advisors
66 holdings
Perceptive Advisors
63 holdings
Baker Bros. Advisors
55 holdings
Live from the dashboard
Real signals from SEC filings, updated daily.
Recent Fund Activity
How it works
Step 01
Every filing, read for you
13F holdings, Form 4 insider trades, activist stakes, and clinical trial data. We parse thousands of SEC filings so you never have to open EDGAR again.
Step 02
Noise removed, meaning added
Every signal gets a two-sentence analyst note: was that insider sale routine or a conviction trade? The data is public — the interpretation is the product.
Step 03
Your weekly brief, before the market opens
Every Monday you get a personalized digest: which funds moved, what insiders traded, and which catalysts are imminent. The rest of the week, you just invest.
Everything a biotech analyst would do for you. Automated.
Reads every SEC filing, tracks every catalyst, never takes a day off. For less than a dollar a day.
13F Fund Tracking
Never miss a position change from Baker Bros, Perceptive, OrbiMed, or any of the 20 funds we track. New positions, increases, trims, and exits — the moment they file.
Fund Convergence
When 3+ specialist funds independently buy the same stock, something is happening. We surface this automatically — no cross-referencing 20 separate filings.
The "So What" on Every Signal
A fund bought shares. So what? Our AI reads the catalyst calendar, cash position, and insider activity — then tells you why this move matters right now.
Catalyst Calendar
PDUFA dates, Phase 3 readouts, AdCom meetings — with outcome tracking. Know what's coming before the market does.
Cash Runway
Which of your holdings has 2 quarters of cash left? We pull burn rates from 10-Q filings so you see dilution risk before the offering drops.
Watchlist Alerts
Star a ticker. Get an email when Baker Bros takes a position, an insider buys, or a catalyst date moves. Your portfolio, monitored.
Built on SEC EDGAR filings, ClinicalTrials.gov data, and FDA calendar events. Updated daily. Contextualized by AI.
Research & white papers
Academic evidence behind the signals. Why insider trades, 13F filings, and fund convergence predict biotech returns.
Simple pricing
One plan. Full access. Cancel anytime.
14-day free trial included
- Track 20 specialist biotech hedge funds — every position change, every quarter
- Every signal comes with a 2-sentence "so what" from AI
- Catalyst calendar, insider trades, and short squeeze screener included
- Monday morning digest personalized to your watchlist
Card required · No charge for 14 days · Cancel anytime
Not investment advice. Data sourced from public SEC filings.
Frequently asked questions
How is this different from BPIQ or WhaleWisdom?
They're databases. We're the analyst who reads the database and writes you a brief. WhaleWisdom shows you that a fund holds a stock. We tell you how much, whether they're adding or trimming, what catalyst is coming, and what their insider is doing with their own money. The difference is between data and insight.
Where does the data come from?
All data is sourced directly from SEC EDGAR filings (13F, Form 4, 13D/13G), ClinicalTrials.gov for catalyst events, and FDA calendar dates. We parse and normalize the raw filings automatically.
How often is the data updated?
Form 4 insider signals and 13D/G activist stakes are ingested daily. 13F fund positions are updated quarterly as funds file. Catalyst data is refreshed weekly from ClinicalTrials.gov.
How accurate is the AI context?
The AI context is generated from structured data — SEC filings, clinical trial records, and financial metrics. It summarizes what the data shows, not predictions. Think of it as having an analyst read every filing for you and write a 2-sentence brief.
Can I cancel anytime?
Yes. Cancel from your dashboard at any time. No contracts, no commitments. Your access continues through the end of your billing period.
Free weekly brief
Every Monday: which funds moved, who's buying inside, what catalysts hit.
Read biotech's smartest money like a book
Every fund position. Every insider trade. Every catalyst. Contextualized, filtered, and in your inbox Monday morning.
Start 14-Day Free Trial$29/mo after trial · Cancel anytime